News & Articles

Eurofins will use DuPont assays to identify probiotics at the strain level

AMSBIO has introduced new CRISPR / Cas9 editing kits for gene knock-out, gene knock-in and gene mutation applications

Novel DNA repair enzyme gives insight into chemotherapy resistant tumors and neurodegenerative disorders

Learn how a lab in the US is fighting malaria on two fronts - through advancing our understanding of host genetic factors that predispose individuals to the severe forms of the disease and finding new therapeutics against the malarial parasite

The highly anticipated platform was launched by Repositive at AACR annual meeting

Earlham Institute boosts national capability in genomics and single cell analysis with ultra-high throughput sequencing platform from Illumina

A recent study from University of Edinburgh aims to pinpoint genes that may be associated with depression

New 2D tube with external thread from Micronic provides a simpler way to build your genomic libraries

To be in with a chance of winning a $500/£400/450€ Amazon voucher, just tell us which new product, instrument or consumable made the most difference to your lab in 2017

Which new product, instrument or consumable has made the most difference to your lab? Nominate now for a chance to win a $500 Amazon voucher

Researchers at Southwest Jiaotong University have identified serine and sphingolipid synthesis as the Achilles heel of aneuploid cancer cells

Register now to discover new, expert perspectives on process design, scale-up, and product safety

From cancer cells to ocean microbes to Zika virus: Read the interviews that made the most impact in 2017

Dr. Michael Bianchi, senior lab manager at Empire Genomics explains the fundamental basis of a successful experiment – a protocol that works well.

Smokers may be predisposed to their habit because of the molecular make-up of their brain, research suggests.

Dr. Bruce Conklin, UCSF, discusses the potential of genome engineering as a therapy for genetic diseases

Dr. Andy Golden, senior investigator at the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), explores the value of C. elegans as an animal model for research

Mission Bio closes Series A funding and launches Tapestri™ to accelerate the discovery, development and delivery of precision medicine

Dr. Stephen Chanock, National Cancer Institute, shares the latest cancer epidemiology studies at the NIH and the team’s hopes of being able to predict and prevent disease